This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Acceleron Pharma, Inc.
Drug Names(s): ACE2494, ACE 2494
Description: ACE-2494 is a therapeutic candidate that traps ligands in the Transforming Growth Factor-Beta (TGF-ß) superfamily involved in the regulation of muscle mass and strength. ACE-2494 has been designed to selectively bind several key negative regulators of muscle mass and thereby increase muscle mass and strength.
Pink Sheet Chart: FDA Recalls & Court Actions
Additional information available to subscribers only: